Pre-Open Stock Movers 04/18: Casa Systems and Natus Medical Higher; TG Therapeutics and Nektar Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies
April 19, 2022 8:36 AM EDTJefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "During Monday morning's press conference TG announced it's pausing its oncology programs. The decision was made based on updated... More
Northland Capital Markets Upgrades Casa Sytems, Inc. (CASA) to Outperform as Verizon Win is 'Game Changing'
April 19, 2022 7:48 AM EDTNorthland Capital Markets analyst Tim Savageaux upgraded Casa Sytems, Inc. (NASDAQ: CASA) from Market Perform to Outperform with a price target of $10 following the Verizon win which it called "game changing."
The analyst commented, "After years of engagement and trials with... More
Synchrony Financial (SYF) PT Raised to $52 at BMO Capital
April 19, 2022 7:36 AM EDTBMO Capital analyst James Fotheringham raised the price target on Synchrony Financial (NYSE: SYF) to $52.00 (from $49.00) while maintaining a Outperform rating following results.
The analyst commented, "Following SYFs 1Q22 broad-based beat, we raise estimates by up to 6% (better NII and credit) and increase our... More
